USD10
ALKS Ações
Sobre AlkermesAlkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.
USD10
ALKS Ações
Sobre AlkermesAlkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.
Estatísticas
JANELA DE NEGOCIAÇÃO
Aberta
ENCERRA ÀS
20:00 GMT+0
CAPITALIZAÇÃO DE MERCADO
US$ 4,87 bi
PREÇO ABERTO
US$ 29,16
BAIXO (1 A)
US$ 25,17
ALTO (1 A)
US$ 36,45
BAIXO (24H)
US$ 29,13
ALTO (24H)
US$ 30,00
VOLUME (24H)
US$ 360,92 mil
75,93%
Histórico de preços
Time | Price | Change |
|---|---|---|
Hoje | US$ 29,16 | |
1 dia | US$ 29,31 | |
1 semana | US$ 27,45 |